State Street
RPTX

State Street’s Repare Therapeutics RPTX Stock Holding History

State Street’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-19,098
Closed -$26.5K – 4360
2025
Q2 		$26.5K Sell
19,098
-303
-2% -$395 ﹤0.01% 4177
2025
Q1 		$19.1K Sell
19,401
-606
-3% -$730 ﹤0.01% 4208
2024
Q4 		$26.2K Sell
20,007
-202
-1% -$602 ﹤0.01% 4200
2024
Q3 		$69.5K Buy
20,209
+404
+2% +$1.33K ﹤0.01% 4047
2024
Q2 		$65.4K Hold
19,805
– – ﹤0.01% 4096
2024
Q1 		$93.3K Sell
19,805
-2,828
-12% -$18.1K ﹤0.01% 4041
2023
Q4 		$165K Sell
22,633
-31,306
-58% -$175K ﹤0.01% 3942
2023
Q3 		$652K Buy
53,939
+438
+0.8% +$4.52K ﹤0.01% 3613
2023
Q2 		$566K Sell
53,501
-298
-0.6% -$3.07K ﹤0.01% 3661
2023
Q1 		$529K Buy
53,799
+469
+0.9% +$5.38K ﹤0.01% 3728
2022
Q4 		$784K Sell
53,330
-145
-0.3% -$2.17K ﹤0.01% 3621
2022
Q3 		$649K Buy
53,475
+648
+1% +$8.34K ﹤0.01% 3686
2022
Q2 		$739K Sell
52,827
-27,523
-34% -$324K ﹤0.01% 3700
2022
Q1 		$1.14M Buy
80,350
+17,956
+29% +$266K ﹤0.01% 3767
2021
Q4 		$1.32M Buy
62,394
+35,805
+135% +$843K ﹤0.01% 3749
2021
Q3 		$698K Buy
26,589
+11,506
+76% +$372K ﹤0.01% 3873
2021
Q2 		$470K Buy
+15,083
New +$494K ﹤0.01% 3880
2021
Q1 		– Sell
-6,035
Closed -$207K – 3983
2020
Q4 		$207K Buy
+6,035
New +$180K ﹤0.01% 3750

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return

State Street's RPTX Position: Q3 2025 in Review

State Street sold out of Repare Therapeutics (RPTX) in Q3 2025, closing a stake of 19,098 shares — an estimated $26.5K sold.

State Street first reported a position in RPTX in Q4 2020 and held it in 18 quarters. The position peaked at $1.32M in Q4 2021. 45 funds tracked by Wall St. Rank hold RPTX as of Q3 2025.

  • State Street reported no remaining Repare Therapeutics position as of Q3 2025 after selling out during the quarter.
  • State Street sold 19,098 Repare Therapeutics shares in Q3 2025, an estimated $26.5K.
  • State Street first reported a position in Repare Therapeutics in Q4 2020 and held it in 18 quarters.
  • State Street's Repare Therapeutics position peaked at $1.32M in Q4 2021.
  • 45 funds tracked by Wall St. Rank held Repare Therapeutics as of Q3 2025.

Based on State Street's 13F filing for Q3 2025, filed 14 Nov 2025.